Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Samuel Eugene Lynch currently holds 1,300,546 shares of BIOMIMETIC THERAPEUTICS, INC. (BMTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Samuel Eugene Lynch has been a net seller of BMTI stock. They have purchased $455.1K and sold $5.7M worth of shares.
Samuel Eugene Lynch's most recent insider trade was on Mar 1, 2013, when they sold 1,392,923 shares at $0.00 per share.
Samuel Eugene Lynch serves as Executive at BIOMIMETIC THERAPEUTICS, INC. (BMTI). They have executed 204 insider transactions totaling $6.2M over their tenure at the company.
Samuel Eugene Lynch holds the position of Executive at BIOMIMETIC THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Samuel Eugene Lynch has shown a selling trading pattern, with $455.1K in total purchases and $5.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Samuel Eugene Lynch was on Mar 1, 2013, when they sold $704.0K worth of BMTI shares. This transaction involved 77,623 shares at $9.07 per share.
Samuel Eugene Lynch currently owns 1,300,546 shares of BIOMIMETIC THERAPEUTICS, INC. (BMTI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Samuel Eugene Lynch's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Samuel Eugene Lynch has 204 Form 4 filings on record as an insider at BIOMIMETIC THERAPEUTICS, INC..
Set alerts for Samuel Eugene Lynch and 40,000+ other insiders.